Search Within

Robert Motzer

  1. "Biostatistics Service"
Formats
  1. Journal Article (62)
  2. Meeting Abstract (60)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (123)
  2. Department of Medicine (123)
  3. Epidemiology and Biostatistics (123)
  4. Genitourinary Oncology Service (123)
  5. Solid Tumor Oncology Division (123)
  6. Surgery (72)

More Groups

People
  1. Sujata Patil (93)
  2. Darren Feldman (78)
  3. Martin Voss (58)
  4. Abraham Hakimi (42)
  5. George Bosl (33)
  6. Chung-Han Lee (31)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (5)
  5. 2021 (9)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (65)
  2. Cancer (8)
  3. Clinical Genitourinary Cancer (8)
  4. Clinical Cancer Research (4)
  5. Investigational New Drugs (3)
  6. Journal of Urology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (66)
  2. Elsevier Inc. (12)
  3. Wiley Blackwell (10)
  4. American Association for Cancer Research (6)
  5. Elsevier Science, Inc. (5)
  6. Nature Publishing Group (4)

More Publishers

Results (123)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant
    Meeting Abstract

    Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)
    Meeting Abstract

    Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter randomized phase 2 trial of paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Appleman, L. J.; Milowsky, M. I.; Patil, S.; Bromberg, M.; Nolan, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF)
    Meeting Abstract

    Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Mukherjee, S.; Mandelker, D.; Vijai, J.; Kemel, Y.; Zhang, L.; Knezevic, A.; Patil, S.; Ceyhan-Birsoy, O.; Huang, K. C.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Genomic alterations and outcomes with VEGF-targeted therapy in patients with clear cell renal cell carcinoma
    Journal Article

    Carlo, M. I.; Manley, B.; Patil, S.; Woo, K. M.; Coskey, D. T.; Redzematovic, A.; Arcila, M.; Ladanyi, M.; Lee, W.; Chen, Y. B.; more...
    Kidney Cancer (2017)

    Fulltext@MSK | Save
  • Histologic determinants of long-term overall survival in patients (pts) with germ cell tumors (GCT)
    Meeting Abstract

    Funt, S.; Patil, S.; Feldman, D. R.; Motzer, R. J.; Bajorin, D. F.; Sheinfeld, J.; Tickoo, S.; Reuter, V. E.; Bosl, G. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save